These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1279970)
1. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Gravett CP; Buckmaster JG; Watson PT; Gravett MG Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970 [TBL] [Abstract][Full Text] [Related]
2. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]. Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497 [TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
4. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Spencer K Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476 [TBL] [Abstract][Full Text] [Related]
5. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Benn PA; Horne D; Briganti S; Rodis JF; Clive JM Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527 [TBL] [Abstract][Full Text] [Related]
6. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
7. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614 [TBL] [Abstract][Full Text] [Related]
10. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA; Spencer K; Abushoufa RA Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [TBL] [Abstract][Full Text] [Related]
11. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935 [TBL] [Abstract][Full Text] [Related]
12. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Luckas M; Hawe J; Meekins J; Neilson J; Walkinshaw S Acta Obstet Gynecol Scand; 1998 Apr; 77(4):381-4. PubMed ID: 9598944 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249 [TBL] [Abstract][Full Text] [Related]
14. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504 [TBL] [Abstract][Full Text] [Related]
15. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224 [TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome. Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896 [TBL] [Abstract][Full Text] [Related]
18. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia. Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876 [TBL] [Abstract][Full Text] [Related]
19. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
20. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. Sritippayawan S; Vachirasrisoontra C J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]